Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heinz Ludwig

Showing results (1-10 of 245) with videos related to

Pageof 25
Sort By:
Blood|November 6, 2010
BMP-2: a culprit for anemia in myelomaHeinz Ludwig
Nature Clinical Practice. Oncology|March 22, 2007
Is bortezomib active in patients with mantle cell lymphoma?Heinz Ludwig
Oncology (Williston Park, N.Y.)|April 7, 2004
Supportive therapies in the management of myelomaHeinz Ludwig,
MMW Fortschritte Der Medizin|February 13, 2003
[Rethinking in oncology. More quality of life for patients by information? (interview by Christine Vetter)]Heinz Ludwig
The Lancet. Haematology|May 30, 2020
Daratumumab: a game changer in myeloma therapyHeinz Ludwig
Blood Cancer Journal|September 18, 2021
Myeloma research on the moveHeinz Ludwig
Future Oncology (London, England)|March 25, 2006
Epoetin beta in oncology: examining the current evidenceHeinz Ludwig
The Lancet. Oncology|July 13, 2016
Early treatment for high-risk smouldering myeloma: has the time come?Heinz Ludwig
The Lancet. Oncology|February 8, 2003
ESMO committed to improving cancer educationHeinz Ludwig,
Seminars in Oncology|June 26, 2002
Anemia of hematologic malignancies: what are the treatment options?Heinz Ludwig
Pageof 25

Showing results (1-10 of 245) with videos related to

Sort By:
Pageof 25
Blood|November 6, 2010
BMP-2: a culprit for anemia in myelomaHeinz Ludwig
Nature Clinical Practice. Oncology|March 22, 2007
Is bortezomib active in patients with mantle cell lymphoma?Heinz Ludwig
Oncology (Williston Park, N.Y.)|April 7, 2004
Supportive therapies in the management of myelomaHeinz Ludwig,
MMW Fortschritte Der Medizin|February 13, 2003
[Rethinking in oncology. More quality of life for patients by information? (interview by Christine Vetter)]Heinz Ludwig
The Lancet. Haematology|May 30, 2020
Daratumumab: a game changer in myeloma therapyHeinz Ludwig
Blood Cancer Journal|September 18, 2021
Myeloma research on the moveHeinz Ludwig
Future Oncology (London, England)|March 25, 2006
Epoetin beta in oncology: examining the current evidenceHeinz Ludwig
The Lancet. Oncology|July 13, 2016
Early treatment for high-risk smouldering myeloma: has the time come?Heinz Ludwig
The Lancet. Oncology|February 8, 2003
ESMO committed to improving cancer educationHeinz Ludwig,
Seminars in Oncology|June 26, 2002
Anemia of hematologic malignancies: what are the treatment options?Heinz Ludwig
Pageof 25